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Many surgical techniques are available for bridging peripheral nerve defects. Autologous nerve grafts are the
current gold standard for most clinical conditions. In selected cases, alternative types of conduits can be used.
Although most efforts are today directed towards the development of artificial synthetic nerve guides, the use of
non-nervous autologous tissue-based conduits (biological tubulization) can still be considered a valuable alternative
to nerve autografts. In this paper we will overview the advancements in biological tubulization of nerve defects,
with either mono-component or multiple-component autotransplants, with a special focus on the use of a vein
segment filled with skeletal muscle fibers, a technique that has been widely investigated in our laboratory and that
has already been successfully introduced in the clinical practice.
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Schwann cellsIntroduction
Nerves are complex organs that are present in almost all
tissues of the human body [1] making nerve injury a very
common casualty [2]. If nerve continuity is lost, surgical
reconstruction is required for reconnecting nerve ends
and if substance loss occurs the two stumps must be
bridged [3-8]. Whereas autologous nerve grafts have been
the most widely used strategy for bridging nerve gaps
nonetheless this technique has disadvantages [9,10]. This
observation, together with the awareness that, although
possible, nerve repair and regeneration is far from being
optimal [11,12], stimulated the investigation of alternative
(non-nervous) conduits for repairing severe nerve defects
[3,13].
In recent years, a great impulse to research in this area
has been certainly represented by the significant develop-
ments in materials sciences, with the increasing availability
of a number of new biomaterials and innovative manufac-
turing procedures [3]. However, translation to the patient
of artificial synthetic nerve grafts is still limited in spite of
the large body of pre-clinical research and, today, the most
popular approach is still biological tubulization, i.e. the
use of non-nervous autologous tissues for creating a scaf-
fold for bridging a nerve gap. In fact, this approach is less* Correspondence: bruno.battiston@virgilio.it
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external body inflammatory reaction.
The aim of this review is to overview the most prom-
ising options for both mono-component and multiple-
component autotransplants in nerve reconstruction
outlining the perspectives of their translation to clinical
application.Mono-component biological conduits
The first attempts to use non-nervous tissues for bridg-
ing a nerve defect dates back to the nineteen century
and, since then, many different approaches have been
tested experimentally and sometimes also with patients.
As far as our knowledge is concerned, the first attempts
to bridge nerve defects with a non-nervous tissue autograft
was carried out by Neuber [14], Gluck [15] and Vanlair in
the second half of the 19th Century [16,17]. These authors
reported the use of pieces of decalcified bone for making
nerve bridges. This approach, that was soon abandoned
since the results were very poor, was followed by many
other attempts to create nerve guides based on the use of
autologous tissues reviewed in [8,18,19].
Among the various attempts, two approaches led to par-
ticularly good results both in pre-clinical animal models and
with patients, namely blood vessels and skeletal muscles
and, in the following paragraphs we will focus on the use of
these two types of autotransplants for nerve reconstruction.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Among the various different types of biologic tubes that
have been experienced so far for bridging a peripheral
nerve gaps, those based on the use of blood vessels as
source of conduit material have been undoubtfully the
most popular because of their large availability in the hu-
man body. Büngner, already in 1891 [20], was the first who
tested a blood vessel, namely an artery segment, for repair-
ing nerve gaps with good regeneration outcome. Although
several other studies about the use of arteries as nerve
guides were published in the following years [21-25], the
clinical use of arteries for nerve tubulization is limited
because of the difficulty in safely harvesting arteries of ap-
propriate size in a patient. Therefore, the interest of re-
searchers and clinicians has shifted to the use of vein
segments. It was Wrede [26] in 190929, the first who de-
scribed the clinical use of veins for repairing nerve lesions
with substance loss, reporting functional recovery after a
45-mm median nerve gap reconstruction. This report was
followed by several others describing the successful use of
veins as nerve guides [27-32]. The demonstration in ex-
perimental animal models that veins can lead to functional
recovery comparable to autogenous nerve grafting [33,34],
were followed by noteworthy clinical studies by Walton
et al. [35] and Chiu et al. [36] that reported satisfactory
functional recovery after sensory nerve repair by means of
vein grafts, comparable to traditional autografts. The effi-
cacy of vein grafts in bridging nerve defects in patients has
been confirmed in various selected clinical conditions, such
as when autologous nerve grafts are insufficient [37], for
microsurgical repair of the sural nerve after nerve biopsy
[38], and for repair of the inferior alveolar branch of the
mandibular division of the trigeminal nerve following iatro-
genic damage [39]. A recent prospective randomized study
comparing polyglycolic acid and autogenous vein scaffolds
for reconstruction of digital nerve gaps showed that recov-
ery after reconstruction with a vein conduit was equivalent
to polyglycolic acid conduit repair with fewer postoperative
complications [40].
However, most of these studies showed that vein grafts
are effective only for short nerve defects, an element that
clearly represent a main limiting factor in the employ-
ment of this technique [41].
Skeletal muscle
The idea of using skeletal muscle fibers for guiding regen-
eration across nerve gaps comes from the observation of
the regular longitudinal alignment of muscle fibers, and
especially their basal lamina, resembles the endoneurial
tubes of degenerating nerves [42-44]. According to our
knowledge, the first use of skeletal muscle scaffolds for
nerve reconstruction was reported in 1940 by Kraus [45],
followed by a series of studies which confirmed the effi-
cacy of this approach for nerve reconstruction [44,46-51].Up to now, only few clinical studies have been published
reporting the used of muscle fiber grafts for repairing
nerve defects in patients. In a series of interesting clinical
papers published in the first half of the Nineties, satisfac-
tory functional recovery was reported in most patients
after reconstruction of nerve defects up to 6 cm [52-57].
In spite of these positive clinical results, the use of nerve
guides made of skeletal muscle alone did not spread
among surgeons so far.
Multiple-component biological conduits
Whereas some of the mono-component biological con-
duits, in particular veins, have led to clinical applications,
their employment is usually limited to bridging short nerve
gaps and they did not gain great clinical acceptance mostly
because vein-based conduits tends to collapse [41].
For this reason, various multiple-component combined
biological conduits have been devised. These constructs
can be based on the combination of either different tis-
sues and organs, or the enrichment of tissue and organs
with cells, trophic factors, and gene transfer.
Multiple-tissue conduits
As regards the first option (the combination of different
tissues and organs), one of the most interesting methods
that have been devised is the use of vein conduits with
the interposition of nerve tissue [58-60]. Although this
method proved to be effective in repairing nerve defects
between 2.0 cm and 4.5 cm in patients [59], it did not
see a significant diffusion among clinicians.
Another interesting approach, is the use of a vein con-
duit filled with either fresh or pre-degenerated skeletal
muscle. While the latter approach has only been addressed
by few studies [61,62] because of the demonstration that
pre-degeneration is not a pre-requisite for promoting
nerve regeneration [63], the use of fresh skeletal muscle fi-
bers has attracted much attention since the successful ex-
perimental validation of this paradigm by Brunelli et al.
[64]. Experimental studies in laboratory animal models
have shown that the fresh muscle-vein-combined guides
are rapidly colonized by migratory Schwann cells (espe-
cially coming back from the distal nerve end) and that
these cells maintain the capability to actively proliferate in-
side the conduit [65-67]. Transmission electron micros-
copy investigation showed that most of the grafted skeletal
muscle fibers degenerate completely over the first postop-
erative days [64] and that new endoneurial tubes are
formed very soon by perineurial cells [67].
RNA expression analysis along fresh muscle-vein com-
bined conduits showed that degenerating skeletal muscle fi-
bers activate an autotrophic loop based on the NRG1/ErbB
system. Since the same autotrophic loop is also shared by
Schwann cells, the presence of degenerating muscle tissue
support Schwann cell survival and activity also by secreting
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nerve regeneration phases [68,69].
Quantitative assessment of both nerve fiber regeneration
(using stereological methods) and functional recovery
(using the grasping test) showed that the muscle-vein-
combined technique lead to nerve regeneration almost
comparably to autograft reconstruction, in comparison to
which it avoids the secondary damage due to the healthy
nerve withdrawal [13].
Yet, the muscle-vein-combined technique proved also
to be effective for the simultaneous repair of two distal
nerve stumps using a single proximal stump only thanks
to the possibility to prepare Y-shaped conduits [70-72].
Due to its efficacy, the muscle-vein-combined nerve
repair technique has already been applied in clinical case
series in selected conditions such as when autograft re-
pair was not possible [73], primary crush injuries [74]
and digital nerve repair [75,76]. All clinical reports have
consistently shown good clinical outcome in most cases
with percentage of functional recovery similar to autolo-
gous nerve grafting. In addition, if nerve reconstruction
is performed soon after lesion, the possibility of delayed
autograft repair is still possible in case of failure of re-
generation [74].
Potentiation of biological conduits with cells, trophic
factors or gene transfer
In alternative to the combination of different tissues/or-
gans, some authors have attempted to enrich vein con-
duits with cells and/or trophic factors.
Various experimental studies showed that cell enrich-
ment of nerve guides leads to better regeneration and re-
covery of the damaged nerve [77-82]. Zhang et al. [80]
and Strauch et al. [78] showed that enriching a vein con-
duit with Schwann cells leads to successful regeneration
across nerve defects as long as 40 and 60 mm (gap lengths
that are not bridgeable by vein conduits alone). In the clin-
ical viewpoint, recent progress in stem cell biology [83,84],
permits to foresee that Schwann cells can even be ob-
tained from stem cells (such as mesenchymal stem cells)
harvested from the same patient [85-87].
Recently, Nijuhis et al. [82] carried out an interesting ex-
perimental study comparing repair of 15-mm sciatic nerve
defect either with a vein filled with fresh skeletal muscle
or with a vein filled with fresh skeletal muscle and bone
marrow derived stem cells showing a tendency of the lat-
ter approach to outperforming the former one although
data do not demonstrate sufficient benefit to warrant clin-
ical implementation of stem cell enriched muscle-vein-
combined conduits at this stage.
As regards trophic factor enrichment, Pu et al. [88]
showed that the enriching autogenous vein grafts with
nerve growth factor (NGF) improved regeneration across a
10-mm long gap of the rat sciatic nerve. The effectivenessof NGF-enriched veins as nerve conduits was confirmed by
Gravannis et al. [89], using the more challenging 12-mm
long gap model in the rat sciatic nerve.
Finally, also the potentiation of regeneration in the repair
of the peripheral nervous system by gene transfer is getting
more and more interest [90-93]. In a recent study, gene
therapy has been associated with muscle-vein-combined
conduits to bridge 10-mm long median nerve defects in the
rat [94]. Whereas muscle-vein-combined scaffolds proved
to be a good means for delivering gene therapy to regener-
ating nerve, results showed that particular attention should
be paid in identifying the adequate gene to be transferred in
order to avoid negative side effects which might even hin-
der the repair process and reduce functional recovery.
Conclusions
Although regeneration potential in the peripheral ner-
vous system is higher in comparison to the central ner-
vous system and thus a satisfactory degree of recovery
after peripheral nerve trauma can be obtained, none-
theless functional recovery is far from being optimal
[1,3,11,13,95,96]. Whereas most research efforts have
been directed to artificial scaffolds for bridging nerve
gaps, the use of non-nervous (and thus less precious) au-
tologous tissue as grafting material (biological tubuliza-
tion) is still receiving interest from many researchers and
has seen a significant spread into the clinics, in selected
clinical conditions [73-76].
In particular, the use of multiple-component conduits
hold promises since many experimental studies have
shown that these types of nerve guides lead to a better
outcome in comparison to conduits made by single com-
ponents alone. Two main pieces of information arise from
relevant literature. First, it has been shown that multiple-
component conduits can lead to similar nerve regener-
ation results in comparison to traditional nerve autografts.
Second, it has been shown that critical gap length limits of
single-component conduits can be overcome by combined
biological conduits. In particular, as regards the muscle-
vein-combined technique, clinical results showed satisfac-
tory recovery after reconstruction of nerve defects up to
4 cm in digital nerves [75] and up to 6 cm in mixed nerves
of the forearm [73].
Finally, combined biological tubulization techniques, such
as muscle-vein-combined nerve repair, hold also interesting
perspectives in terms of tissue engineering of the peripheral
nerves due to the recent demonstration that skeletal muscle
fibers can be successfully infected by adeno-associated vi-
ruses (AAVs) to increase the local delivery of selected mole-
cules (gene therapy) [94].
In conclusion, although artificial synthetic tubulization is
seeing great advancements, biological tubulization still
holds interesting perspectives, especially if it will be used in
combination with innovative tissue engineering approaches,
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approaches are still not ready for clinical translation
and the risk of negative side effects must always be care-
fully ruled out in pre-clinical experiments [94,97], hope-
fully optimization of tubulization techniques would
eventually provide the surgeon with an extra-amount of
grafting material (with sufficient graft length too) that
could be used in severe cases with multiple and large
nerve substance loss.
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